drugset / Trial / NCT01643590
Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, double-blind, placebo controlled Phase II study is designed to assess the safety and efficacy of using JVS-100 to treat heart failure.
Timeline
- Start
- 2012-07
- Primary completion
- 2014-10
- Completion
- 2014-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | JVS-100 | Other / unclassified | 15 mg | Other |
| Subject | JVS-100 | Other / unclassified | 30 mg | Other |